India to double drug inspectors to boost oversight

MUMBAI Wed May 21, 2014 7:08pm IST

Pictures of Hindu gods hang beside a medicines rack inside a clinic in Pune August 27, 2012. REUTERS/Danish Siddiqui/Files

Pictures of Hindu gods hang beside a medicines rack inside a clinic in Pune August 27, 2012.

Credit: Reuters/Danish Siddiqui/Files

Related Topics

Rajalakshmi (C), 28, smiles after winning the Miss Wheelchair India beauty pageant in Mumbai November 26, 2014. REUTERS/Danish Siddiqui

Miss Wheelchair India

Seven women from across India participated in the country's second wheelchair beauty pageant, which aims to open doors for the wheelchair-bound in modelling, film and television, according to organisers  Slideshow 

MUMBAI (Reuters) - India will spend 30 billion rupees ($511 million) and double the number of drug inspectors in the next three years to meet global manufacturing standards, the country's health regulator said on Wednesday.

A rash of import bans imposed by the U.S. Food and Drug Administration on leading Indian generic drugmakers due to lapses in production processes over the past year has triggered concerns about the quality of drugs sold in other markets, including in India.

The government will increase the number of inspectors at the Central Drugs Standard Control Organization (CDSCO) to 1,000 from 500 now, Drugs Controller General of India G.N. Singh said in a statement on Wednesday.

The number of officials at state regulatory departments will be raised to 3,000 from 800 now, he said.

"India's reference system (for drug testing and intellectual property) will be at par with the top world standards in two to three years and will even match theĀ U.S. in three to five years," Singh said.

In India, states regulate the manufacture and distribution of drugs, while CDSCO, which is the federal authority, handles approvals of new drugs and clinical trials, oversees drug imports and coordinates the activities of state regulators.

A chronic shortage of inspectors has made it difficult for regulators to monitor the more than 10,000 drug manufacturing factories in India, which supply to more than 200 countries.

Multiple state drug regulators told Reuters in April that skeletal staff and lack of enough drug testing laboratories had rendered their departments unequipped to carry out their duties.

($1 = 58.7600 Indian Rupees)

(Reporting by Zeba Siddiqui in Mumbai; Editing by Prateek Chatterjee)

FILED UNDER:

REUTERS SHOWCASE

WTO Trade Deal

WTO Trade Deal

WTO clinches first global trade deal in its history  Full Article 

Kashmir Attack

Kashmir Attack

Ten dead in Kashmir's worst militant attack in more than a year  Read 

OPEC Meeting

OPEC Meeting

Saudis block OPEC output cut, oil price sinks further.  Full Article 

E-Commerce Boom

E-Commerce Boom

Online grocers come up trumps in India's e-commerce boom   Full Article 

GDP, RBI Preview

GDP, RBI Preview

GDP growth set to weaken, business wants reforms more than rate cut  Full Article | Related Story 

Jaitley to Rajan

Jaitley to Rajan

Jaitley likely to meet Rajan on Monday to urge rate cut  Full Article 

Banking Sector

Banking Sector

India moves to allow more businesses to offer basic financial services.  Full Article 

Jamini Roy

Jamini Roy

Photo Gallery – Bengali household name Jamini Roy’s paintings  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device  Full Coverage